Reversible posterior encephalopathy syndrome induced by cyclosporine
10.3760/cma.j.issn.1008-5734.2017.01.016
- VernacularTitle:环孢素致可逆性后部脑病综合征
- Author:
Yang LIU
1
;
Liyun ZHANG
1
;
Gailian ZHANG
1
;
Ke XU
1
;
Jinfang GAO
1
Author Information
1. 山西医科大学附属大医院风湿免疫科, 太原,030000
- Publication Type:Journal Article
- Keywords:
Cyclosporine;
Posterior leukoencephalopathy syndrome
- From:
Adverse Drug Reactions Journal
2017;19(1):63-64
- CountryChina
- Language:Chinese
-
Abstract:
A 60-year-old woman with connective tissue disease received cyclosporine 300 mg once daily . On day 2 of adding cyclosporine, the patient developed pharyngalgia. On day 3, she developed hematochezia, abdominal distension and abdominal pain. On day 14, she lost her vision of both eyes, developed attacks of binoculus transient upper left gaze twice, a slight headache, and the elevated blood pressure (150/90 mmHg). Laboratory tests showed that the cyclosporine blood concentration was 372. 4μg/L. The results of cranial MRI showed bilateral frontal, parietal, occipital and temporal lobes symmetrical multiple patchy long T1, long T2 signals, the fluid attenuated inversion recovery sequence showed high signal, which suggested the vascular edema. The patient was diagnosed as reversible posterior encephalopathy syndrome due to cyclosporine. Cyclosporine was stopped immediately. She received an IV infusion of methylprednisolone 40 mg once daily and other symptomatic supportive treatments including deprivation of body fluids, anti-epileptic, and blood pressure control, etc. On day 5 of treatment, her vision began to recover, but she had blurred vision and visual hallucinations. On day 7 of treatment, the degree of abdominal distension and abdominal pain was relieved, vision was recovered obviously, visual hallucination disappeared. Her blood pressure returned to normal (125/86 mmHg). The result of laboratory tests showed the cyclosporine blood concentration 139. 2 μg/L. The result of MRI reexamination showed that the original focus disappeared.
